Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Molecular function of Cdk5 in pain signaling elucidated

Jan. 2, 2007

Novel analgesic agents revealed in recent patents

Jan. 2, 2007

AstraZeneca to continue development of AZD-3480

Jan. 2, 2007

Azilect disease modification study in early Parkinson's completes enrollment

Jan. 2, 2007

mGluR2/3 antagonist LY-341495 exerts antidepressant activity in rodents

Jan. 2, 2007

Compounds for possible use in anxiety, depression, etc., claimed in recent patents

Dec. 29, 2006

Clinical efficacy and safety of bifeprunox reported in patients with acute and stable schizophrenia

Dec. 29, 2006

Volinanserin enhances the antidepressant effects of desipramine and tranylcypromine in rats

Dec. 29, 2006

Topline phase I findings for AZ-003

Dec. 29, 2006

Labopharm files complete response to once-daily tramadol approvable letter

Dec. 29, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...